Halozyme Therapeutics, Inc.

Artisan Partners Limited Partnership HALO

Report date

9/30/2025

Quarter

2025 Q3

Filed

11/12/2025

Shares

62,591

Value ($000)

4,590

Weight

0.0%

2019 Q4 - 2025 Q3 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	11/12/2025	4,590	0.0%	62,591	9/30/2025
2025 Q2	8/12/2025	42,383	0.1%	814,741	6/30/2025
2025 Q1	5/14/2025	72,657	0.1%	1,138,651	3/31/2025
2024 Q4	2/12/2025	65,647	0.1%	1,373,089	12/31/2024
2024 Q3	11/12/2024	179,357	0.3%	3,133,412	9/30/2024
2024 Q2	8/12/2024	194,636	0.3%	3,717,264	6/30/2024
2024 Q1	5/13/2024	154,227	0.2%	3,791,230	3/31/2024
2023 Q4	2/12/2024	247,228	0.4%	6,689,058	12/31/2023
2023 Q3	11/9/2023	294,632	0.5%	7,712,874	9/30/2023
2023 Q2	8/10/2023	269,065	0.4%	7,459,511	6/30/2023
2023 Q1	5/11/2023	267,032	0.4%	6,992,189	3/31/2023
2022 Q4	2/10/2023	406,320	0.7%	7,140,953	12/31/2022
2022 Q3	11/10/2022	242,297	0.4%	6,127,892	9/30/2022
2022 Q2	8/12/2022	280,076	0.5%	6,365,361	6/30/2022
2022 Q1	5/13/2022	370,313	0.5%	9,285,686	3/31/2022
2021 Q4	2/11/2022	382,227	0.5%	9,505,768	12/31/2021
2021 Q3	11/12/2021	409,917	0.5%	10,076,613	9/30/2021
2021 Q2	8/12/2021	462,714	0.6%	10,189,688	6/30/2021
2021 Q1	5/11/2021	436,418	0.6%	10,468,159	3/31/2021
2020 Q4	2/10/2021	439,235	0.6%	10,284,136	12/31/2020
2020 Q3	11/12/2020	407,811	0.6%	15,517,924	9/30/2020
2020 Q2	8/12/2020	450,607	0.7%	16,807,413	6/30/2020
2020 Q1	5/12/2020	259,596	0.6%	14,430,037	3/31/2020
2019 Q4	2/12/2020	93,269	0.2%	5,260,496	12/31/2019